Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients-Reference-Cited by-同舟云学术

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Published:2020-09 Issue: Volume:44 Page:102251
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Whittam Daniel H^ORCID,Cobo-Calvo Alvaro,Lopez-Chiriboga A Sebastian,Pardo Santiago,Gornall Matthew,Cicconi Silvia,Brandt Alexander,Berek Klaus^ORCID,Berger Thomas,Jelcic Ilijas,Gombolay Grace,Oliveira Luana Micheli,Callegaro Dagoberto,Kaneko Kimihiko,Misu Tatsuro^ORCID,Capobianco Marco,Gibbons Emily,Karthikeayan Venkatraman,Brochet Bruno^ORCID,Audoin Bertrand,Mathey Guillaume,Laplaud David,Thouvenot Eric,Cohen Mikaël^ORCID,Tourbah Ayman,Maillart Elisabeth,Ciron Jonathan^ORCID,Deschamps Romain,Biotti Damien^ORCID,Rostasy Kevin,Neuteboom Rinze,Hemingway Cheryl,Forsyth Rob,Matiello Marcelo,Webb Stewart,Hunt David,Murray Katy,Hacohen Yael,Lim Ming,Leite M Isabel,Palace Jacqueline,Solomon Tom,Lutterotti Andreas,Fujihara Kazuo,Nakashima Ichiro^ORCID,Bennett Jeffrey L,Pandit Lekha,Chitnis Tanuja^ORCID,Weinshenker Brian G^ORCID,Wildemann Brigitte,Sato Douglas Kazutoshi^ORCID,Kim Su-Hyun,Huda Saif,Kim Ho Jin^ORCID,Reindl Markus,Levy Michael,Jarius Sven,Tenembaum Silvia,Paul Friedemann,Pittock Sean,Marignier Romain,Jacob Anu

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference37 articles.

1. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein;O'Connor;Nat Med,2007

2. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders;Mader;J Neuroinflammation,2011

3. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype;Kitley;Neurology,2012

4. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders;Lopez-Chiriboga;JAMA Neurol,2018

5. Clinical presentation and prognosis in MOG-antibody disease: A UK study;Jurynczyk;Brain,2017

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of tocilizumab in highly relapsing MOGAD with an inadequate response to intravenous immunoglobulin therapy: A case series;Multiple Sclerosis and Related Disorders;2024-11

2. Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks;Neurology;2024-09-24

3. NMOSD and MOGAD: an evolving disease spectrum;Nature Reviews Neurology;2024-09-13

4. Aggressive Course of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): An Illustration of Two Cases and Review of Literature;Cureus;2024-09-03

5. Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes;European Journal of Paediatric Neurology;2024-09